The 5'-->3' exonuclease from beef spleen is a 160-kDa tetramer consisting of four subunits of two types. Partial reduction of the tetramer led to one stable intermediate state of the enzyme with Mr = 80 kDa. The aim of this paper was to attribute the exonucleolytic activity to one of the two monomers, to the dimer or to the tetramer. The different forms of the exonuclease were separated by SDS-polyacrylamide gel electrophoresis, transferred on an Immobilon-P membrane and subsequently renaturated. Antibodies monospecific against each of the two monomers as well as against the dimer were isolated and their inhibitory effect on the holoenzyme determined. It was found that after renaturation the two monomers did not possess any exonuclease activity while the 80-kDa dimer showed a lower recovery of the specific activity of the enzyme (20.8+/-0.23 nkat/nmol, (n = 5)) in comparison with the 160-kDa tetramer (64.8+/-0.75 nkat/nmol (n = 5)). It was demonstrated that the antibodies monospecific against the dimer caused 53% maximum inhibition of the 160-kDa exonuclease. The antibodies monospecific against 25- and 55-kDa monomers did not inhibit the activity of the holoenzyme. No single-strand endonuclease activity of the spleen exonuclease was observed when using supercoiled Bluescript KS+ plasmid DNA as a substrate. This data suggest the emergence of an 80 kDa active form of beef spleen exonuclease upon association of two monomers of the tetrameric enzyme.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s1357-2725(99)00108-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Single 3'-exonuclease-based multifragment DNA assembly method (SENAX).
Sci Rep
March 2022
Department of Biomedical Engineering, National University of Singapore, Singapore, Singapore.
Article Synopsis
- DNA assembly is crucial in biotechnology for designing DNA plasmids that help engineer microorganisms for various applications.* -
- The new method, SENAX, utilizes a specific enzyme to efficiently assemble multiple DNA fragments at low temperatures, allowing for short overlapping sequences and overcoming limitations of existing technologies.* -
- SENAX also enables a modular and cost-effective approach to DNA assembly, allowing for the reuse of common bioparts, simplifying the construction process in synthetic biology.*
Design, synthesis, and biological evaluation of novel urolithins derivatives as potential phosphodiesterase II inhibitors.
Sci Rep
December 2021
School of Pharmaceutical Engineering & Life Science, Changzhou University, Changzhou, 213164, China.
A series of urolithins derivatives were designed and synthesized, and their structures have been confirmed by H NMR, C NMR, and HR-MS. The inhibitory activity of these derivatives on phosphodiesterase II (PDE2) was thoroughly studied with 3-hydroxy-8-methyl-6H-benzo[C]chromen-6-one and 3-hydroxy-7,8,9,10-tetrahydro-6H-benzo[C] chromen-6-one as the lead compounds. The biological activity test showed that compound 2e had the best inhibitory activity on PDE2 with an IC of 33.
View Article and Find Full Text PDFDesign, Synthesis, and Biological Evaluation of Novel 6-Benzo[]chromen-6-one Derivatives as Potential Phosphodiesterase II Inhibitors.
Int J Mol Sci
May 2021
School of Pharmaceutical Engineering & Life Science, Changzhou University, Changzhou 213164, China.
Urolithins (hydroxylated 6-benzo[]chromen-6-ones) are the main bioavailable metabolites of ellagic acid (EA), which was shown to be a cognitive enhancer in the treatment of neurodegenerative diseases. As part of this research, a series of alkoxylated 6-benzo[]chromen-6-one derivatives were designed and synthesized. Furthermore, their biological activities were evaluated as potential PDE2 inhibitors, and the alkoxylated 6-benzo[]chromen-6-one derivative was found to have the optimal inhibitory potential (IC: 3.
View Article and Find Full Text PDFSynthesis of 2'-O-alkylcarbamoylethyl-modified oligonucleotides with enhanced nuclease resistance that form isostable duplexes with complementary RNA.
Bioorg Med Chem Lett
March 2021
Department of Life Science and Technology, Tokyo Institute of Technology, 4259 Nagatsuta-cho, Midori-ku, Yokohama 226-8501, Japan. Electronic address:
To expand the variety of 2'-O-modified oligonucleotides, we synthesized 2'-O-carbamoylethyl-modified oligonucleotides bearing ethyl, n-propyl, n-butyl, n-pentyl, and n-octyl groups on their nitrogen atoms. The corresponding nucleosides were synthesized using 2'-O-benzyloxycarbonylethylthymidine, which was easily converted into the carboxylic acid through hydrogeneration; subsequent condensation with the appropriate amine gave the desired nucleoside. We evaluated the effect of the 2'-O-alkylcarbamoylethyl modifications on duplex stability by analyzing melting temperature, which revealed the formation of isostable duplexes.
View Article and Find Full Text PDFEster modification at the 3' end of anti-microRNA oligonucleotides increases potency of microRNA inhibition.
Bioorg Med Chem
January 2021
Department of Chemistry, University of California, One Shields Avenue, Davis, CA 95616, United States. Electronic address:
MicroRNAs (miRNAs) are short noncoding RNAs that play a fundamental role in gene regulation. Deregulation of miRNA expression has a strong correlation with disease and antisense oligonucleotides that bind and inhibit miRNAs associated with disease have therapeutic potential. Current research on the chemical modification of anti-miRNA oligonucleotides (anti-miRs) is focused on alterations of the phosphodiester-ribose backbone to improve nuclease resistance and binding affinity to miRNA strands.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!